Goldman Sachs analyst James Schneider expressed views on International Business Machines Corporation‘s (NYSE:IBM) Investor Day, which took place on February 4.
The analyst maintained a Buy rating and a $275 price forecast, considering the company remains underappreciated in the TMT sector and offers discovery value, especially for long-only investors.
The analyst notes that IBM projects over 5% total revenue growth from 2025 to 2027, including M&A, with pre-tax margin and FCF growth outpacing revenue growth.
The analyst notes the stock should continue to rise, as IBM has outlined a credible strategy to sustain accelerated long-term Software revenue growth of around 10%, surpassing their previous expectation of high-single digits for 2025-2027.
Moreover, Schneider notes that IBM raised its medium-term Software revenue growth target to 10%, up from mid-single digits, with Red Hat seeing mid-teens growth.
The analyst sees a potential upside in IBM’s Software growth and margins, fueled by increasing demand for containerization, OpenShift, Ansible, and RHEL.
Additionally, IBM’s early leadership in GenAI, with ~$1 billion in Software GenAI bookings to date, presents further growth opportunities, adds the analyst.
Also, the analyst notes that IBM expects Consulting business to outperform the market through share gains, and Infrastructure business is forecasted to grow 1%-3%, on mainframe and storage growth.
Overall, the analyst notes the company is on track to achieve long-term growth driven by stronger software growth and market share gains in the consulting business.
Last month, IBM reported fourth-quarter earnings of $3.92 per share, which beat the analyst consensus estimate of $3.75. Quarterly revenue came in at $17.55 billion, which beat the analyst consensus estimate of $17.54 billion.
Investors can gain exposure to the stock via First Trust NASDAQ Technology Dividend Index Fund (NASDAQ:TDIV) and FT Vest Technology Dividend Target Income ETF (BATS:TDVI).
Price Action: IBM shares are down 0.80% at $262.33 at the last check Wednesday.
Read Next:
Photo via Shutterstock.
Date | Firm | Action | From | To |
---|---|---|---|---|
Jan 2022 | BMO Capital | Maintains | Market Perform | |
Jan 2022 | UBS | Downgrades | Neutral | Sell |
Jan 2022 | Goldman Sachs | Initiates Coverage On | Neutral |
View More Analyst Ratings for IBM
View the Latest Analyst Ratings
Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market.
Get the latest stock analysis from Benzinga?
This article IBM Story Is Underappreciated, Goldman Sachs Says Stock Can Re-Rate Higher originally appeared on Benzinga.com
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。